These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 12921472
1. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000. Greenhill LL, Vitiello B, Abikoff H, Levine J, March JS, Riddle MA, Capasso L, Cooper TB, Davies M, Fisher P, Findling RL, Fried J, Labellarte MJ, McCracken JT, McMahon D, Robinson J, Skrobala A, Scahill L, Varipatis E, Walkup JT, Zito JM. J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):651-5. PubMed ID: 12921472 [Abstract] [Full Text] [Related]
2. How can we improve the assessment of safety in child and adolescent psychopharmacology? Vitiello B, Riddle MA, Greenhill LL, March JS, Levine J, Schachar RJ, Abikoff H, Zito JM, McCracken JT, Walkup JT, Findling RL, Robinson J, Cooper TB, Davies M, Varipatis E, Labellarte MJ, Scahill L, Capasso L. J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):634-41. PubMed ID: 12921470 [Abstract] [Full Text] [Related]
3. Review of safety assessment methods used in pediatric psychopharmacology. Greenhill LL, Vitiello B, Riddle MA, Fisher P, Shockey E, March JS, Levine J, Fried J, Abikoff H, Zito JM, McCracken JT, Findling RL, Robinson J, Cooper TB, Davies M, Varipatis E, Labellarte MJ, Scahill L, Walkup JT, Capasso L, Rosengarten J. J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):627-33. PubMed ID: 12921469 [Abstract] [Full Text] [Related]
4. Ethical issues in psychopharmacology of children and adolescents. Koelch M, Schnoor K, Fegert JM. Curr Opin Psychiatry; 2008 Nov; 21(6):598-605. PubMed ID: 18852568 [Abstract] [Full Text] [Related]
5. The NCI All Ireland Cancer Conference. Johnston PG, Daly PA, Liu E. Oncologist; 1999 Nov; 4(4):275-277. PubMed ID: 10545862 [Abstract] [Full Text] [Related]
6. Phase IV research by pharmaceutical companies. Hakkarainen H, Hattab JR, Venulet J. Pharmacopsychiatry; 1984 Sep; 17(5):168-75. PubMed ID: 6494246 [Abstract] [Full Text] [Related]
7. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE, Kleijnen J. Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [Abstract] [Full Text] [Related]
9. Drug safety in psychiatry--an objective for drug monitoring in phase IV. Schmidt LG, Müller-Oerlinghausen B. Pharmacopsychiatry; 1984 Sep; 17(5):152-6. PubMed ID: 6494244 [Abstract] [Full Text] [Related]
12. Traditional and alternative research designs and methods in clinical pediatric psychopharmacology. Fava M. J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1292-303. PubMed ID: 8885583 [Abstract] [Full Text] [Related]
13. The relevance of prolonged QTc measurement to pediatric psychopharmacology. Labellarte MJ, Crosson JE, Riddle MA. J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):642-50. PubMed ID: 12921471 [Abstract] [Full Text] [Related]
17. Annual meeting of the New Clinical Drug Evaluation Units (NCDEU) program, Psychopharmacology Research Branch, National Institute of Mental Health, 23-25 May 1978, Key Biscayne, Florida. Psychopharmacol Bull; 1979 Jul; 15(3):22-44. PubMed ID: 493456 [No Abstract] [Full Text] [Related]
18. Psychopharmacology for children: from off label use to registration. Wohlfarth T, Kalverdijk L, Rademaker C, Schothorst P, Minderaa R, Gispen-de Wied C. Eur Neuropsychopharmacol; 2009 Aug; 19(8):603-8. PubMed ID: 19428221 [Abstract] [Full Text] [Related]